NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed ...
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed ...
Source: pr-inside.com
Growth Plus Reports News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Growth Plus Reports. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Growth Plus Reports Today - Breaking & Trending Today
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock
SHELTON, CT / ACCESSWIRE / April 30, 2024 / NanoViricides, Inc. (NYSE Amer:NNVC) (the "Company"), a global leader in broad-spectrum antiviral nanomedicines, reports that the Phase I Clinical Trial of NV-387 is completed successfully and data lock is expected soon.The Phase 1 clinical trial, protocol number...
Source: pharmiweb.com
Genomics in Cancer Care Market is set to Reach US$ 28.52
Pune, Feb. 22, 2024 (GLOBE NEWSWIRE) -- According to the latest report published by Growth Plus Reports, the global Genomics in Cancer Care Market is...
Source: globenewswire.com
Carrier Screening Market is set to Reach US$ 5.00 billion
Pune, Feb. 20, 2024 (GLOBE NEWSWIRE) -- According to the latest report published by Growth Plus Reports, the global Carrier Screening Market is expected...
Source: globenewswire.com
Neuroprotective Agents Market is set to Reach US$ 143.78
Pune, Feb. 19, 2024 (GLOBE NEWSWIRE) -- According to the latest report published by Growth Plus Reports, the global Neuroprotective Agents Market is...
Source: globenewswire.com